• Humanigen to enter Asia-Pacific market with Covid-19 drug pharmaceutical-technology
    November 06, 2020
    Humanigen has executed a licensing agreement with Telcon RF Pharmaceutical and KPM Tech for development and commercialisation rights of its Covid-19 drug lenzilumab for South Korea and the Philippines.
PharmaSources Customer Service